Molecular dynamics simulations of DARPins as potential inhibitors against cancer associated protein kinases / Vertika Gautam
Out of all post-translational modifications, Protein phosphorylation is the most common in signal transduction, that occurs through protein kinases. Extracellular Regulated Kinase 2 (ERK2) is a type of protein kinase that undergoes phosphorylation to control various pathological and physiological ph...
| Main Author: | Vertika , Gautam |
|---|---|
| Format: | Thesis |
| Published: |
2021
|
| Subjects: | |
| Online Access: | http://studentsrepo.um.edu.my/12833/ http://studentsrepo.um.edu.my/12833/2/Vertika_Gautam.pdf http://studentsrepo.um.edu.my/12833/1/Vertika_Gautam.pdf |
Similar Items
Theoretically engineered DARPins targetting DENV-2 envelope protein / Chong Wei Lim
by: Chong , Wei Lim
Published: (2021)
by: Chong , Wei Lim
Published: (2021)
Evaluation of transcriptional cyclin dependent kinase inhibitors as potential cancer therapeutics
by: Liu, Xiangrui
Published: (2012)
by: Liu, Xiangrui
Published: (2012)
Antibiofilm activities of protein kinase inhibitors against Salmonella enterica serovar typhimurium / Mohd Fakharul Zaman Raja Yahya
by: Mohd Fakharul Zaman , Raja Yahya
Published: (2018)
by: Mohd Fakharul Zaman , Raja Yahya
Published: (2018)
EGFR-directed tyrosine kinase inhibitors for non-small cell lung cancer
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025)
Identification of potential riboflavin synthase inhibitors by virtual screening and molecular dynamics simulation studies
by: Mohamad Aris, Sayangku Nor Ariati, et al.
Published: (2021)
by: Mohamad Aris, Sayangku Nor Ariati, et al.
Published: (2021)
Usnic acid as potential inhibitors of BCL2 and P13K protein through network pharmacology-based analysis, molecular docking and molecular dynamic simulation
by: Wong, K. K. V., et al.
Published: (2023)
by: Wong, K. K. V., et al.
Published: (2023)
Adaptive therapy to circumvent drug resistance to tyrosine kinase inhibitors in cancer: is it clinically relevant?
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)
by: Hamdi, Amir Imran Faisal, et al.
Published: (2022)
A quest on finding new potential ebola vp40 inhibitors: molecular docking and molecular dynamics simulation studies
by: Mohamad Yussoff, Mohamad Ariff, et al.
Published: (2018)
by: Mohamad Yussoff, Mohamad Ariff, et al.
Published: (2018)
Case series of small cell lung cancer transformation post tyrosine kinase inhibitor failure
by: Chai, C.S., et al.
Published: (2017)
by: Chai, C.S., et al.
Published: (2017)
3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA
by: Wang, R., et al.
Published: (2010)
by: Wang, R., et al.
Published: (2010)
Linifanib – a multi-targeted receptor tyrosine kinase inhibitor and a low molecular weight gelator
by: Marlow, Maria, et al.
Published: (2015)
by: Marlow, Maria, et al.
Published: (2015)
Probing polyoxometalate-protein interactions using molecular dynamics simulations
by: Solé-Daura, Albert, et al.
Published: (2016)
by: Solé-Daura, Albert, et al.
Published: (2016)
Molecular alterations of Ras-Raf-mitogen-activated protein kinase and phosphatidylinositol 3-kinase-Akt signaling pathways in colorectal cancers from a tertiary hospital at Kuala Lumpur, Malaysia
by: Yip, Wai Kien, et al.
Published: (2013)
by: Yip, Wai Kien, et al.
Published: (2013)
Phosphorylation And Regulation
Of Human Choline Kinase Beta
By Protein Kinase A
by: Chang , Ching Ching
Published: (2015)
by: Chang , Ching Ching
Published: (2015)
Phosphorylation And Regulation
Of Human Choline Kinase Beta
By Protein Kinase A
by: Chang , Ching Ching
Published: (2015)
by: Chang , Ching Ching
Published: (2015)
An investigation into the effects of the epidermal growth factor receptor tyrosine kinase inhibitor "Gefitinib" on human breast cancer
by: Gutteridge, Eleanor
Published: (2010)
by: Gutteridge, Eleanor
Published: (2010)
Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers
by: Ahmad, Dena Akram Jerjees, et al.
Published: (2016)
by: Ahmad, Dena Akram Jerjees, et al.
Published: (2016)
Protein Kinase C-Delta C2 Domain Interactions in Breast Cancer
by: Khader, Rasha
Published: (2023)
by: Khader, Rasha
Published: (2023)
Spectroscopic and molecular modeling studies on the interaction of tyrosine kinase inhibitors with human serum albumin / Md. Zahirul Kabir
by: Md. Zahirul , Kabir
Published: (2018)
by: Md. Zahirul , Kabir
Published: (2018)
Self-assembling tyrosine kinase inhibitors for localised targeted delivery
by: Al-Ameedee, Mohammed
Published: (2017)
by: Al-Ameedee, Mohammed
Published: (2017)
Identification of Inhibitor Binding Site in Human Sirtuin 2 Using Molecular Docking and Dynamics Simulations
by: Sakkiah, Sugunadevi, et al.
Published: (2013)
by: Sakkiah, Sugunadevi, et al.
Published: (2013)
Performance evaluation of wax inhibitor with sodium cloisite through experimental and molecular dynamics simulation (MD)
by: Priyatachni, Subramanie
Published: (2020)
by: Priyatachni, Subramanie
Published: (2020)
Molecular docking and molecular dynamic simulation of 1,3-Benzoxazine derivatives against penicillin binding protein 2A of methicillin-resistant Staphlyococcus aureus
by: Alharbi, Nourah Jamaan H
Published: (2023)
by: Alharbi, Nourah Jamaan H
Published: (2023)
Discovery of highly potent and selective phosphatidylinositol 3-kinase-δ inhibitors for the treatment of blood cancers and autoimmune diseases
by: Buzrieda, Anas
Published: (2021)
by: Buzrieda, Anas
Published: (2021)
3-phosphoinositide-dependent protein kinase-1 as an emerging target in the management of breast cancer
by: Fyffe, C., et al.
Published: (2013)
by: Fyffe, C., et al.
Published: (2013)
Evaluation of potential bacterial protease inhibitor properties of selected hydroxyquinoline derivatives : An in silico docking and molecular dynamics simulation approach
by: Riaz, Faiza, et al.
Published: (2023)
by: Riaz, Faiza, et al.
Published: (2023)
Identification of anti-proliferative kinase inhibitors as potential therapeutic agents to treat canine osteosarcoma
by: Mauchle, Ulrike, et al.
Published: (2015)
by: Mauchle, Ulrike, et al.
Published: (2015)
An apoferritin-based drug delivery system for the tyrosine kinase inhibitor gefitinib
by: Kuruppu, Anchala I., et al.
Published: (2015)
by: Kuruppu, Anchala I., et al.
Published: (2015)
Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma
by: Abbhi, V., et al.
Published: (2017)
by: Abbhi, V., et al.
Published: (2017)
Phosphoinositide 3-kinase pathway inhibitors: pharmacology, metabolism & drug development
by: Falasca, Marco
Published: (2011)
by: Falasca, Marco
Published: (2011)
Analysis of phosphorylation sites of protein kinases in Cryptosporidium
by: Barudin, Mohd Aiman, et al.
Published: (2018)
by: Barudin, Mohd Aiman, et al.
Published: (2018)
Targeting phosphoinositide 3-kinase pathways in pancreatic cancer - from molecular signalling to clinical trials
by: Falasca, Marco, et al.
Published: (2011)
by: Falasca, Marco, et al.
Published: (2011)
Death-associated protein kinase increases glycolytic rate through binding and activation of pyruvate kinase
by: Mor, I., et al.
Published: (2012)
by: Mor, I., et al.
Published: (2012)
In silico discovery of potential uridine-cytidine kinase 2 inhibitors form the rhizome of Alpina mutica
by: Malami, Ibrahim, et al.
Published: (2016)
by: Malami, Ibrahim, et al.
Published: (2016)
Molecular dynamics simulation study and hybrid pharmacophore model development in human LTA4H inhibitor design
by: Thangapandian, S., et al.
Published: (2012)
by: Thangapandian, S., et al.
Published: (2012)
Case Series of Small Cell Lung Cancer Transformation
as Resistance Mechanism to Epidermal Growth Factor
Receptor-Tyrosine Kinase Inhibitor
by: Liam, C, et al.
Published: (2017)
by: Liam, C, et al.
Published: (2017)
Molecular simulation of protein-ligand complexes
by: Guest, Ellen
Published: (2022)
by: Guest, Ellen
Published: (2022)
Molecular dynamics simulations and Gaussian network model for designing antibody mimicking protein towards dengue envelope protein
by: Chong, Wei Lim, et al.
Published: (2022)
by: Chong, Wei Lim, et al.
Published: (2022)
Activity of the aurora kinase B inhibitor AZD1152 in acute myeloid leukaemia
by: Grundy, Martin
Published: (2012)
by: Grundy, Martin
Published: (2012)
Repressing the activity of protein kinase CK2 releases the brakes on mitochondria-mediated apoptosis in cancer cells
by: Hanif, I., et al.
Published: (2011)
by: Hanif, I., et al.
Published: (2011)
Similar Items
-
Theoretically engineered DARPins targetting DENV-2 envelope protein / Chong Wei Lim
by: Chong , Wei Lim
Published: (2021) -
Evaluation of transcriptional cyclin dependent kinase inhibitors as potential cancer therapeutics
by: Liu, Xiangrui
Published: (2012) -
Antibiofilm activities of protein kinase inhibitors against Salmonella enterica serovar typhimurium / Mohd Fakharul Zaman Raja Yahya
by: Mohd Fakharul Zaman , Raja Yahya
Published: (2018) -
EGFR-directed tyrosine kinase inhibitors for non-small cell lung cancer
by: Fatin Nur Elyana Mohd Sidek,, et al.
Published: (2025) -
Identification of potential riboflavin synthase inhibitors by virtual screening and molecular dynamics simulation studies
by: Mohamad Aris, Sayangku Nor Ariati, et al.
Published: (2021)